Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03908879 · ClinicalTrials.gov registry record · NA

Intraosseous Catheter Confirmation Study

A NA study of Critical Illness, sponsored by Rutgers, The State University of New Jersey.

Completed
Registry status
NA
Development phase
34
Enrollment target
1
Study location

NCT03908879 is a NA study of Critical Illness that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 34 participants, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03908879, a NA study of Critical Illness, has completed, sponsored by Rutgers, The State University of New Jersey.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target
1
Study location

Study Summary

This is a prospective diagnostic accuracy study investigating the sensitivity and specificity of methods used to confirm correct placement of an intraosseous (IO) catheter. Intraosseous catheters allow medical providers to rapidly administer fluids and medications to critically ill patients when intravenous (IV) access is not present or difficult to achieve. It is standard of care to confirm the correct placement of an IO catheter prior to using it to administer medications or fluids. Three IO placement confirmatory tests will be performed on all research subjects using a standardized protocol. There will be two index tests (the method utilized by most of the medical community evaluating the stability of the catheter, ability to aspirate blood or bone marrow and ability to administer fluids without visible or palpable extravasation as well as the method of demonstrating color flow Doppler only within the intraosseous space during bedside ultrasound exam) and one reference test (ability to visualized a pulsatile waveform when the IO catheter is attached to a pressure transducer). Primary outcome measures of the study will be the determination of correct or incorrect IO catheter placement from the confirmation methods. This data will be used to investigate the primary endpoints of sensitivity and specificity of the confirmation tests as well as inter-operator variability interpreting the raw data from the confirmation methods. Secondary outcomes include complications from the IO catheter. The goal of this study is to see if a more sensitive and specific method of IO catheter confirmation can reliably be performed by different physicians and reduce the amount of complications associated with the catheters. Additional subgroup analyses will be performed in regards to the research subjects BMI and the anatomic site selected for IO catheter use (proximal tibia or humeral head).

Conditions Studied

Interventions

  • PROCEDURE Standard intraosseous (IO) catheter confirmation procedure
  • PROCEDURE Color flow Doppler intraosseous (IO) catheter confirmation procedure
  • PROCEDURE Pressure transduction intraosseous (IO) catheter confirmation procedure

Study Locations (1)

New Jersey

  • University Hospital - Newark

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2019-07-23
Est. Completion 2022-05-01
Phase NA

What the Registry Record Tells You About NCT03908879

The ClinicalTrials.gov registry entry for NCT03908879 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (99% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Critical Illness appearing as the primary indexed condition, and to 3 interventions - of which Standard intraosseous (IO) catheter confirmation procedure is the first listed.

NCT03908879 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT03908879 about?

NCT03908879 is a clinical study titled "Intraosseous Catheter Confirmation Study". This is a prospective diagnostic accuracy study investigating the sensitivity and specificity of methods used to confirm correct placement of an intraosseous (IO) catheter. Intraosseous catheters allow medical providers to rapidly administer fluids and medications to critically ill patients when int...

What is the current status of trial NCT03908879?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2019-07-23. Estimated completion is 2022-05-01.

What conditions does trial NCT03908879 study?

This clinical trial studies the following conditions: Critical Illness.

What interventions are being tested in trial NCT03908879?

The interventions under investigation include: Standard intraosseous (IO) catheter confirmation procedure (PROCEDURE), Color flow Doppler intraosseous (IO) catheter confirmation procedure (PROCEDURE), Pressure transduction intraosseous (IO) catheter confirmation procedure (PROCEDURE).

Who is sponsoring clinical trial NCT03908879?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03908879 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.